Rossari Biotech Limited — Others, 20-07-2025: Copy of Newspaper Publication

Rossari Biotech has released its Q1 FY26 consolidated financial results. The company saw robust revenue growth, with total income from operations increasing to Rs 543.72 Cr compared to Rs 489.65 Cr year-on-year. However, net profit after tax slightly declined to Rs 33.60 Cr from Rs 34.90 Cr in the prior-year quarter. This resulted in basic earnings per share (EPS) of Rs 6.07. Investors should note the revenue growth while keeping an eye on the slight profit contraction. The Board approved these results after Audit Committee review.